Agonist
Back to library
MetabolicSubcutaneous

AOD-9604

Also known as: Anti-Obesity Drug 9604 · hGH 177–191 · AOD

Synthetic fragment of human growth hormone C-terminus (residues 177–191). Retains lipolytic activity without the diabetogenic, IGF-1-elevating, or tissue-growth effects of full GH.

At a glance

Half-life
30 minutes
Common route
Subcutaneous
Typical dose range
250–500mcg
Stability (reconstituted)
30days refrigerated

Best timing

Fasted morning, ideally 30 minutes before cardio or first meal. Daily 5-on-2-off cycle common.

Contraindications

  • Pregnancy
  • Severe diabetes (efficacy may be reduced)
  • Known sensitivity to GH-related peptides

Watch symptoms

  • Mild injection site reactions
  • Minimal side effect profile in trials
  • Hunger changes (variable)
  • No significant IGF-1 elevation expected

Citations

The primary literature.

  1. 01The metabolic effects of AOD9604, a fragment of human growth hormone, in obese subjects: a randomized controlled trialPubMed
  2. 02Effect of an analog of the growth hormone (177-191) fragment on body composition in obese micePubMed
Back to library